Insider Move to Note: An Insider Theodore Witek Unloaded 3700 shares of Innoviva Inc (NASDAQ:INVA)

November 23, 2016 - By Vivian Park

Insider Move to Note: An Insider Theodore Witek Unloaded 3700 shares of Innoviva Inc (NASDAQ:INVA)

Theodore Witek Insider Sell

The Sr. VP & Chief Scientific Off. of Innoviva Inc, Theodore Witek is in the stock market news today. It was disclosed in a form filled by Theodore Witek and submitted to the D.C. based-SEC on 22-11-2016, he unloaded 3,700 shares from the Pinksheet-listed Innoviva Inc having an approx. value of $40,123 U.S Dollars. Theodore Witek’s shares average price was $10.8. Theodore Witek now has ownership of 0.14% of Innoviva Inc’s total market cap with ownership of 153,431 shares. 

The stock decreased 0.09% or $0.01 during the last trading session, hitting $10.91. About 621,247 shares traded hands. Innoviva Inc (NASDAQ:INVA) has declined 20.64% since April 20, 2016 and is downtrending. It has underperformed by 25.20% the S&P500.

Innoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The company has a market cap of $1.19 billion. The Firm is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It has a 34.4 P/E ratio. The Company’s portfolio focuses on the respiratory assets partnered with Glaxo Group Limited , including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol (FF/VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)).

According to Zacks Investment Research, “Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company’s portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.”

More recent Innoviva Inc (NASDAQ:INVA) news were published by: Streetinsider.com which released: “Form 3 Innoviva, Inc. For: Nov 18 Filed by: Duncan Barbara Gayle” on November 21, 2016. Also Seekingalpha.com published the news titled: “Innoviva: On Track To Buy Back The Whole Company” on February 04, 2016. Streetinsider.com‘s news article titled: “GlaxoSmithKline (GSK), Innoviva (INVA) Announce Filing of FF/UMEC/VI ..” with publication date: November 21, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>